These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28161631)

  • 1. Reciprocal regulation of miR-1254 and c-Myc in oral squamous cell carcinoma suppresses EMT-mediated metastasis and tumor-initiating properties through MAPK signaling.
    Lu M; Chen WH; Wang CY; Mao CQ; Wang J
    Biochem Biophys Res Commun; 2017 Mar; 484(4):801-807. PubMed ID: 28161631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer.
    Lin X; Lin BW; Chen XL; Zhang BL; Xiao XJ; Shi JS; Lin JD; Chen X
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1464-1470. PubMed ID: 28988111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma.
    Li C; Lin XF; Wang JN; Ren XS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3701-3709. PubMed ID: 32329846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway.
    Peng QS; Cheng YN; Zhang WB; Fan H; Mao QH; Xu P
    Cell Death Dis; 2020 Feb; 11(2):112. PubMed ID: 32041942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
    Wang XC; Ma Y; Meng PS; Han JL; Yu HY; Bi LJ
    Oral Oncol; 2015 Jul; 51(7):674-82. PubMed ID: 25962939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways.
    Dou Z; Gao L; Ren W; Zhang H; Wang X; Li S; Zheng J; Kong X; Chi P; Zhi K
    Exp Cell Res; 2020 Nov; 396(2):112290. PubMed ID: 32956704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
    Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
    Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX1/miR-429 feedback loop promotes growth, metastasis, and epithelial-mesenchymal transition in oral squamous cell carcinoma by targeting ITGB1.
    Lu X; Yang Y; Chen J; Zhao T; Zhao X
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5289-5302. PubMed ID: 38277041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of miR-455-5p by the TGF-β-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B.
    Cheng CM; Shiah SG; Huang CC; Hsiao JR; Chang JY
    J Pathol; 2016 Sep; 240(1):38-49. PubMed ID: 27235675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
    Li L; Ma HQ
    Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
    Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
    Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-1290 targets CCNG2 to promote the metastasis of oral squamous cell carcinoma.
    Qin WJ; Wang WP; Wang XB; Zhang XT; Du JD
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10332-10342. PubMed ID: 31841213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-α-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility.
    Hsing EW; Shiah SG; Peng HY; Chen YW; Chuu CP; Hsiao JR; Lyu PC; Chang JY
    PLoS One; 2019; 14(3):e0213463. PubMed ID: 30893332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
    Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
    Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA LINC00958 promotes the oral squamous cell carcinoma by sponging miR-185-5p/YWHAZ.
    Wang Z; Zhu X; Dong P; Cai J
    Life Sci; 2020 Feb; 242():116782. PubMed ID: 31442551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
    Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM
    Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.